ASX:ILAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
ISLAND PHARMACEUTICALS ORD
$0.400
+$0.025 (+6.67%)
Day Range
$0.380 - $0.410
52 Week Range
$0.130 - $0.630
Volume
194.73K
Avg Volume (10D)
420.73K
Market Cap
$118.37M
Price Chart
Market Statistics
Open$0.380
Previous Close$0.375
Day High$0.410
Day Low$0.380
52 Week High$0.630
52 Week Low$0.130
Valuation
Market Cap118.37M
Shares Outstanding295.92M
Price to Book15.98
Trading Activity
Volume194.73K
Value Traded76.40K
Bid$0.400 × 24,714
Ask$0.410 × 23,255
Performance
1 Day21.43%
5 Day21.43%
13 Week13.33%
52 Week136.11%
YTD-1.16%
Technical Indicators
RSI (14)57.07
50-Day SMA$0.378
200-Day SMA$0.382
Latest News
Biotechnology
Island Pharmaceuticals Strengthens Biodefence Engagement for Galidesivir Advancement
Island Pharmaceuticals strengthens US biodefence push with new adviser Mark Herzog, MC2 roles, and Galidesivir progress toward FDA Animal Rule trials.
1 min read
Biotechnology
Island Pharma Expands Antiviral Pipeline with Burnet Institute Collaboration and NHMRC Funding
Island Pharma expands antiviral pipeline with Burnet Institute; NHMRC grant of over $780k to back ISLA-101, accelerating Galidesivir MVD program.
1 min read
Biotechnology
Island Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal Rule
Island Pharma signs a 3-year CRADA with USAMRIID and Geneva Foundation to fast-track Galidesivir for Marburg under FDA Animal Rule, eyeing NDA.
1 min read
Biotechnology
Island Pharmaceuticals Raises $9m to Fund Clinical Development as FDA Approves Galidesivir Pathway
Island Pharmaceuticals (ASX: ILA) secures FDA Animal Rule path for galidesivir and $9m funding to fast-track two-stage trials and US govt procurement potential.
1 min read
